Month: December 2016
-
Trial to Test Stem Cells for Treating Heart Failure
A clinical trial testing a treatment for heart failure using a patient’s own bone marrow stem cells is recruiting participants at the first two study sites.
-
Brain Cancer Regression Shown with Engineered T-Cells
A patient treated with immune system cells genetically modified to attack his brain cancer reported regression of recurring tumors in the brain and spinal cord.
-
Trial to Test Liquid Biopsy for Breast Cancer Complication
A clinical trial plans to assess the use of a blood test to diagnose neurological complications from the spread of breast cancer.
-
FDA Approves Spinal Muscular Atrophy Drug [Updated]
A drug to treat spinal muscular atrophy, a genetic disorder causing the wasting away of muscle tissue in children and adults, was approved for sale in the U.S.
-
Christmas 2016
26 December 2016. It’s the official Christmas holiday in the USA and many parts of the world, so Science & Enterprise is taking the day off. We will continue our regular posting tomorrow. * * *
-
Genetic Tests, Elec. Health Records Show Hidden Disease
A program that connects mass genetic screening to electronic health records shows a segment of the population tested has an undiagnosed blood disorder causing high cholesterol levels.
-
Solar Reactor Devised for Small-Scale Chemical Production
An engineering group developed a solar-powered catalytic reactor that can produce small amounts of drugs and agricultural chemicals on demand.
-
Smartphone System Shown to Control Blood Glucose Levels
A bionic pancreas system using a smartphone was shown in a clinical trial to control blood glucose levels better than a commercial insulin pump in persons with type 1 diabetes.
-
Spin-Off Creates Enzyme to Prevent Celiac Disease
A spin-off enterprise from University of Washington is developing a synthetic enzyme that prevents dietary gluten from triggering symptoms of celiac disease.
-
Cell Biotech Gains Organoid Technology
A Canadian biotechnology enterprise is licensing a technology that generates organoids, three-dimensional clusters of cells from stem cells that can form into gastrointestinal organs.